Next Quarterly Earnings
Monday, November 2, 2026
Expected
Castle Biosciences
Castle Biosciences is a leading U.S. diagnostics company specializing in innovative genetic tests for dermatology and gastroenterology. Through precise gene expression analysis, Castle Biosciences improves treatment planning and supports physicians in making complex clinical decisions.
Frequently asked questions
When did Castle Biosciences last report quarterly earnings?
Castle Biosciences last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.07 USD.
How often has Castle Biosciences beaten expectations?
Castle Biosciences has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Castle Biosciences earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+17.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Castle Biosciences
Country
🇺🇸
More Financial Information